Table 6.
Exitus in COVID-19 positive patients: univariate analysis (admission).
| Patients, n | Exitus (n = 69) |
No Exitus (n = 318) |
p |
|---|---|---|---|
| Age, years | 78 ± 12 | 63 ± 15 | 0.001 |
| Males, n | 44/69 (63.8%) | 203/318 (63.8%) | NS |
| Body temperature, degree | 37.3 ± 1.08 | 37.9 ± 7.9 | NS |
| Positive medical history: | |||
| Arterial hypertension, n | 47/69 (68%) | 127/318 (39.9%) | 0.001 |
| Cardiomiopathy, n | 36/69 (52.1%) | 62/318 (19.5%) | 0.001 |
| Chronic kidney insufficiency, n | 15/69 (21.7%) | 25/318 (7.9%) | 0.02 |
| COPD, n | 14/69 (20.2%) | 24/318 (7.5%) | 0.001 |
| Diabetes mellitus, n | 16/69 (23.1%) | 49/318 (15.4%) | NS |
| Malignancy, n | 21/69 (30.4%) | 32/317 (10%) | 0.001 |
| Peripheral arterial disease, n | 24/69 (34.8%) | 26/318 (8.2%) | 0.001 |
| Biochemistries at admission: | |||
| Creatinine, mg/dL | 1.44 ± 0.6 | 1.62 ± 8.1 | 0.001 |
| Azotemia, mg/dL | 75.0 ± 50.7 | 47.6 ± 51.0 | 0.001 |
| Oxigen delivery at admission: | |||
| Low flow (Nasal cannulas/masks) | 30/69 (43.5%) | 172/318 (54%) | NS |
| High flow (C-PAP/HFNC) | 40/69 (57.9%) | 152/318 (47.8%) | NS |
| Mechanical ventilation | 2/69 (2.9%) | 70/318 (22%) | 0.001 |
| Medical therapy at admission: | |||
| ACEIs, n | 7/67 (10.5%) | 40/318 (12.6%) | NS |
| ARBs, n | 6/68 (8.9%) | 34/318 (10.7%) | NS |